DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $62 to $53.
DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $53
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.